Beta Bionics, Inc. Common Stock BBNX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $31.58M+3.8% | $30.43M+14.6% | $26.57M— | ||
| $187.55M+156% | $73.14M+4.2% | $70.18M— | ||
| $100K0.0% | $100K0.0% | $100K— | ||
| $49.11M— | —— | $7.82M— | ||
| $75.15M+219% | $23.55M+1,003% | $2.14M— | ||
| $32.56M+454% | $5.88M+298% | $1.48M— | ||
| $267.91M+102% | $132.92M+28.3% | $103.62M— | ||
| $8.6M+80.1% | $4.78M+92.9% | $2.48M— | ||
| $6.63M-0.3% | $6.65M+78.5% | $3.72M— | ||
| $180K+20.0% | $150K+24.0% | $121K— | ||
| $45.43M— | —— | —— | ||
| $328.74M+120% | $149.65M+36.0% | $110.04M— | ||
| $16.34M+269% | $4.43M+160% | $1.7M— | ||
| $22.43M+41.7% | $15.83M+94.7% | $8.13M— | ||
| $3.3M+77.3% | $1.86M+629% | $255K— | ||
| $1.94M+26.7% | $1.53M+24.9% | $1.22M— | ||
| $30.92M+46.2% | $21.15M+99.4% | $10.61M— | ||
| $5.37M-6.3% | $5.73M+90.9% | $3M— | ||
| $7.3M+0.7% | $7.26M— | —— | ||
| $1.55M— | —— | —— | ||
| $41.13M-44.1% | $73.63M+43.2% | $51.43M— | ||
| $4K+300% | $1K— | —— | ||
| $657.14M+1,181% | $51.31M+94.2% | $26.42M— | ||
| -$369.94M-24.7% | -$296.74M-29.2% | -$229.66M— | ||
| $403K+520% | $65K-52.6% | $137K— | ||
| $287.61M+217% | -$245.36M-20.8% | -$203.11M-19.4% | ||
| $328.74M+120% | $149.65M+36.0% | $110.04M— | ||
| $180K+20.0% | $150K+24.0% | $121K— | ||
| $6.63M-0.3% | $6.65M+78.5% | $3.72M— | ||
| $45.43M— | —— | —— | ||
| $6.63M-0.3% | $6.65M+78.5% | $3.72M— | ||
| $180K+20.0% | $150K+24.0% | $121K— | ||
| $187.55M+156% | $73.14M+4.2% | $70.18M— | ||
| $6.63M-0.3% | $6.65M+78.5% | $3.72M— | ||
| $180K+20.0% | $150K+24.0% | $121K— | ||
| $1.56M+65.8% | $939K+979% | $87K— | ||
| $22.43M+41.7% | $15.83M+94.7% | $8.13M— | ||
| $3.3M+77.3% | $1.86M+629% | $255K— | ||
| $7.3M+0.7% | $7.26M+71.8% | $4.22M— | ||
| $4K+300% | $1K— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Beta Bionics, Inc. Common Stock's total assets?
- Beta Bionics, Inc. Common Stock (BBNX) holds $304.4M in total assets, down 9.9% year over year.
- How much debt does Beta Bionics, Inc. Common Stock have?
- Beta Bionics, Inc. Common Stock carries $6.9M in total debt against $271.2M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Beta Bionics, Inc. Common Stock have?
- Beta Bionics, Inc. Common Stock holds $30.2M in cash and equivalents.
- Can Beta Bionics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 10.69 — current assets exceed current liabilities.
- Where does Beta Bionics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
